Stereotactic radiosurgery for 1–10 brain metastases to avoid whole-brain radiotherapy: Results of the CYBER-SPACE randomized phase 2 trial

The more sensitive SPACE sequence did not improve outcomes over MPRAGE. SRS with thorough monitoring and immediate re-treatment for new lesions decreases the need for WBRT and achieves low neurologic death rates. SRS should be considered a favorable alternative to WBRT for patients with 1-10 BM.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2024-09-28
DOI
https://doi.org/10.1093/neuonc/noae201
Citations
15
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
6.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stereotactic radiosurgery for 1–10 brain metastases to avoid whole-brain radiotherapy: Results of the CYBER-SPACE randomized phase 2 trial

Rami A. El Shafie, Simon Höne, Kristin Lang, Thomas Welzel et al.
15 citations
Neuro-Oncology
Brain Metastases and Treatment
6.28
article

Stereotactic radiosurgery for 1–10 brain metastases to avoid whole-brain radiotherapy: Results of the CYBER-SPACE randomized phase 2 trial

Rami A. El Shafie, Simon Höne, Kristin Lang, Thomas Welzel, Farastuk Bozorgmehr, Daniela Schmitt, Laila König, Sinem Erdem, Meinhard Kieser, Cornelia Jäkel, Denise Bernhardt, Sebastian Adeberg, Jürgen Debus, Stefan Rieken, Annabella Schiele, Ursula Nestle, Fabian Weykamp, Paul Thalmann, Michael Thomas, Anja Sander, Adriane Lentz-Hommertgen, Angela Paul
article en
15 citations

Abstract

The more sensitive SPACE sequence did not improve outcomes over MPRAGE. SRS with thorough monitoring and immediate re-treatment for new lesions decreases the need for WBRT and achieves low neurologic death rates. SRS should be considered a favorable alternative to WBRT for patients with 1-10 BM.

Neuro-OncologyVol. 27(2)
Philipps University of Marburg (DE), Zimmer Biomet (Netherlands) (NL), German Cancer Research Center (DE), Heidelberg University (DE), University Medical Center Freiburg (DE), University Hospital Heidelberg (DE), TUM Klinikum (DE), Heidelberger Institut für Radioonkologie (DE), Kliniken Maria Hilf (DE), National Center for Tumor Diseases (DE), Universitätsmedizin Göttingen (DE), German Center for Lung Research (DE), Deutsches Konsortium für Translationale Krebsforschung (DE), Technical University of Munich (DE)
Deutsches Krebsforschungszentrum, Accuray, Universitätsmedizin Göttingen, Technische Universität München, Deutschen Konsortium für Translationale Krebsforschung
Good health and well-being
Openalex Percentile: Top 3%
Brain Metastases and Treatment
6.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.